ZELERIS DIN 02501015
Status: Marketed
Holder: CEVA ANIMAL HEALTH INC
Health Canada record
| Active ingredient(s) | FLORFENICOL 400 MG; MELOXICAM 5 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Subcutaneous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 19-Oct-2020 |
|---|
| Current status date | 19-Oct-2020 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Ceva Animal Health Inc — licence 102054, currently licensed, last inspection rating C (2024-07-31).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLORFENICOL
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02231742 | AQUAFLOR | INTERVET CANADA CORP | Drug Premix | FLORFENICOL 500 G | Marketed |
| 02472953 | CLARO | ELANCO CANADA LIMITED | Solution | FLORFENICOL 16.6 MG; TERBINAFINE (TERBINAFINE HYDROCHLORIDE) 14.8 MG; MOMETASONE FUROATE 2.2 MG | Marketed |
| 02497166 | FENISOLVE | NORBROOK LABORATORIES LTD. | Solution | FLORFENICOL 300 MG | Marketed |
| 02458527 | FLORKEM | CEVA ANIMAL HEALTH INC | Solution | FLORFENICOL 300 MG | Marketed |
| 02216558 | NUFLOR | INTERVET CANADA CORP | Solution | FLORFENICOL 300 MG | Marketed |
| 02526654 | PAQ FLOR | PHIBRO ANIMAL HEALTH CORPORATION | Drug Premix | FLORFENICOL 500 G | Marketed |
| 02330997 | RESFLOR | INTERVET CANADA CORP | Solution | FLORFENICOL 300 MG; FLUNIXIN (FLUNIXIN MEGLUMINE) 16.5 MG | Marketed |
| 02555670 | SIMPLERA | VETOQUINOL N A INC | Solution | FLORFENICOL 16.6 MG; TERBINAFINE HYDROCHLORIDE 16.6 MG; MOMETASONE FUROATE 2.2 MG | Marketed |
| 02287803 | NUFLOR | INTERVET CANADA CORP | Solution | FLORFENICOL 23 MG | Cancelled Post Market |
| 02339579 | NUFLOR 4% PREMIX | INTERVET CANADA CORP | Drug Premix | FLORFENICOL 40 G | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 23837 | 2020-06-25 | New Drug Submission (NDS) | |
Request a quote for ZELERIS
How to read a Canadian DIN record